Study: AI Could Save 5-10% in Healthcare Spending
|
By HospiMedica International staff writers Posted on 30 Jan 2023 |

A new study by McKinsey & Company (New York City, NY, USA) and Harvard University (Cambridge, MA, USA) estimates that the broader adoption of AI could lead to savings in the range of 5% to 10% in healthcare spending, or between approximately USD 200-360 billion per year in the US.
Presently, the healthcare sector has low adoption of AI-based tools despite its benefits discovered by researchers. The study's estimates are based on AI uses utilizing current technologies that are achievable within the next five years, without compromising quality or access. Hospitals could see cost savings mainly through improved clinical operations, quality and safety – such as optimizing operating rooms, or identifying adverse events. Physician groups can experience similar benefits by leveraging AI for continuity of care, such as referral management.
Health insurers could experience savings from uses that improve claims management, such as automating prior authorization, along with healthcare and provider relationship management, including preventing readmissions and provider directory management. Based on AI-driven uses, private payers could save approximately 7% to 9% of their total costs within the next five years. Physician groups could save 3% to 8% of their costs. Additionally, the report estimates that hospitals could register savings between 4% to 11% in their expenses per year.
Related Links:
McKinsey & Company
Harvard University
Latest Business News
- World Health Expo to Showcase Trillion-Dollar Growth Across Pharma, Biotech, Longevity and Wellness at 2027 Edition
- Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery
- Robotic Single-Port System Gains CE Mark for Transvaginal Gynecologic Procedures
- Smartphone-Integrated Epinephrine Auto-Injector Concept Wins Red Dot Design Award
- Partnership Advances AI Tool for Predicting Malignant Cerebral Edema
- First U.S. Commercial Cases Demonstrate New Approach to Transseptal Access
- Philips and Imricor Collaboration Advances MRI-Guided Cardiac Procedures
- FDA Approval Clears Path for BCI Integration with Personal Computing Devices
- Abbott LAA Occluder Gains CE Mark for AFib Stroke Risk Reduction
- Smart Hospital Market Set for Strong Growth as Digital Healthcare Adoption Accelerates
- FDA Seeks Feedback on Regulating Generative AI Medical Devices
- Teledyne to Acquire Varex Imaging in $1.1 Billion Deal
- MIMEDX to Add Sanara MedTech’s Regenerative Technologies Through $350 Million Deal
- AI Software Combines Nodule Detection and Diagnosis for Lung Cancer Screening
- AI Care Platform Adds Quantitative MRI Analysis for Multiple Sclerosis
- Danaher Completes Acquisition of Masimo to Expand Patient Monitoring Capabilities
Channels
Artificial Intelligence
view channel
Predictive Model Supports Growth Hormone Treatment Planning in Idiopathic Short Stature
Idiopathic short stature (ISS) describes children whose height is substantially below the expected range for age and sex without an identifiable medical cause. Recombinant growth hormone therapy can support... Read more
AI Model Predicts Prolonged Sitting in Chronic Pelvic Pain
Chronic pelvic pain affects an estimated one in seven women and can occur with conditions such as endometriosis, adenomyosis, or uterine fibroids. Pain, fatigue, and other symptoms may contribute to prolonged... Read moreCritical Care
view channel
Wearable Patch Prototype Advances Toward Integrated Automated Insulin Delivery
Diabetes management requires individualized care, reliable glucose and ketone monitoring, and timely intervention. For automated insulin delivery, a key challenge is maintaining accurate glucose measurements... Read more
AI Tool Combining ECG and Blood Tests Reduces Unnecessary Heart Transplant Biopsies
Cardiac transplant rejection occurs when a recipient’s immune system attacks a donated heart. Diagnosis currently relies on biopsy, an invasive procedure in which heart muscle tissue is removed and examined... Read more
Deep Brain Stimulation Window May Matter for Parkinson’s Patients With GBA1 Variants
Patients with GBA1 gene variants may develop significant physical symptoms earlier in life while also facing greater vulnerability to cognitive problems. This combination can complicate decisions about... Read moreFDA-Approved App Enables Pulmonary Pressure Monitoring and Medication Guidance in Heart Failure
Heart failure is a chronic, progressive condition and a leading cause of hospitalization, with clinical status often deteriorating before symptoms appear. Rising pulmonary artery pressure can precede decompensation... Read moreSurgical Techniques
view channel
FDA Clears Antibiotic-Delivering Spacer for Infected Knee Replacements
Periprosthetic joint infection develops around an artificial joint implant and can be especially difficult to manage after knee replacement. Treatment may require removal of the implant, prolonged infection... Read more
Matrix-Based Skin Substitute Improves Closure of Diabetic Foot Ulcers
Diabetic foot ulcers are hard-to-heal wounds that can persist because of chronic inflammation and moisture imbalance. When standard care alone does not achieve timely closure, clinicians may use adjunctive... Read morePatient Care
view channel
At-Home Neuromodulation Shows Promise in Selected Patients With Hypertension
High blood pressure is a major risk factor for cardiovascular disease, including heart attack and stroke. Many patients receiving treatment for hypertension still remain above recommended blood pressure... Read more
EHR Model Flags High-Risk Periods in Patients with Metastatic Breast Cancer
Determining when patients with metastatic breast cancer are nearing the end of life remains difficult, often leading to intensive interventions with limited benefit. Prognostic uncertainty can delay goals-of-care... Read moreMedical Imaging
view channel
PSMA PET/CT-Guided Biopsy Improves Detection of Significant Prostate Cancer After Nondiagnostic MRI
Prostate cancer can be difficult to detect when magnetic resonance imaging (MRI) findings are negative or inconclusive. Men with persistent clinical risk factors may still require biopsy, yet standard... Read more
AI Software Detects Osteoporosis from Routine CT Scans
Osteoporosis can progress for years without pain, leaving bone loss undetected until a fracture or back pain prompts testing. By that point, bone loss may already be advanced. Bone density testing is not... Read more
AI Model Uses Pretreatment CT Scans to Predict Immunotherapy-Related Pneumonitis Risk
Pneumonitis is a potentially life-threatening form of lung inflammation that affects about 10% of patients with lung cancer receiving immunotherapy. Because it can be difficult to predict before symptoms... Read moreHealth IT
view channel
Adaptive Radiation QA Software Gains Validation for NeoArc Treatments
Adaptive radiation therapy allows clinicians to adjust treatment plans to daily anatomical changes such as tumor shrinkage, weight loss, or organ movement, improving precision while limiting exposure to... Read more
Healthcare Database Helps Close Long COVID Surveillance Gap
Long COVID is a chronic condition that occurs after SARS-CoV-2 infection and lasts at least three months. It can follow severe illness, but it can also affect anyone who has been infected.... Read morePoint of Care
view channel
Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes
Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more







